ag-Ip-news

The Only Specialized Global Intellectual Property News Agency
A Member of Talal Abu-Ghazaleh Organization
Arabic
Advanced Search
Mailing List Sign Up
Enter your e-mail address to receive daily headlines.

Unsubscribe
Click here for World Law news from NewsNow.co.uk
WAP Service


AGIPNEWS3997

15/2/2007 10:48 GMT
ag-IP-news
IP-news Agency

NEW YORK - A conference titled “Strategies for Managing Intellectual Pro

Special to ag-IP-news Agency

NEW YORK - Public Patent Foundation (PUBPAT) Executive Director, Dan Ravicher, will testify on Thursday before the US House of Representatives on the subject of patent reform.

Ravicher will begin with an opening statement and then answer questions from representatives on the Subcommittee on Courts, the Internet, and Intellectual Property (IP), including Chairman Howard Berman (D-CA) and Ranking Member Howard Coble (R-NC), at the oversight hearing on "American Innovation at Risk: The Case for Patent Reform".

"The interests of the non-patent holding public are almost always absent from any meaningful participation in decision making about the patent system, despite the fact that they bear the brunt of its burdens," Ravicher stated in written testimony submitted as part of his testimony at the hearing.

Patent reform has been a topic of extensive discussion in Washington the past few years, with both the House and Senate introducing bills and holding hearings on the subject.

Many of the most frequently discussed proposals aim to improve patent quality, such as by limiting the ability of patent applicants to file unlimited numbers of continuation applications and by creating a post-grant opposition procedure allowing the public to more efficiently challenge the validity of issued patents.

In his written testimony, Ravicher commented on these specific proposals and also raised several other ways in which the patent system should be reformed.


Related Articles
Alnylam Receives Notice of Allowance from USPTO
Lipoxen's Polysialylated G-CSF StimuXen Technology Granted European Patent
China IP Offices Close for Spring Festival Holiday
Patent Office Grants EFF Request for Reexamination of Dangerous VoIP Patent
Repligen Receives Notice of Allowance for Recombinant Protein A Patent
Labopharm Receives FDA Approval for OLEPTRO
Cleveland BioLabs Granted European Patent for Radiation Protection Drug CBLB502
LogRhythm Granted Comprehensive US Patent
AUSTAR and Rovi Sign IPG Patent License Agreement
Court Issues Order Construing Disputed Terms in Neutral Tandem Patent Infringement Case

Top
Go

Home | About Us | How to Use Our Services | Links | Download Our News Ticker | FAQ | What is IP? | Contact Us
Copyright © 2008 ag-IP-news All Rights Reserved
Disclaimer   Terms of Use    Privacy Policy